Canada
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
53.21%
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
2 |
26.89%
|
Jan. 28, 2024 | USD 414.20 | -1.65% |
|
Canada |
|
3 |
25.15%
|
Dec. 31, 2023 | USD 7.37 | 1.49% |
|
Canada |
|
4 |
23.25%
|
Dec. 31, 2023 | USD 52.50 | 1.95% |
|
Canada |
|
5 |
20.43%
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
6 |
18.76%
|
Dec. 31, 2023 | USD 49.82 | 0.09% |
|
Canada |
|
7 |
18.32%
|
March 31, 2024 | USD 10.66 | 0.87% |
|
Canada |
|
8 |
17.05%
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
9 |
16.09%
|
Dec. 31, 2023 | USD 23.12 | -1.32% |
|
Canada |
|
10 |
14.22%
|
Feb. 29, 2024 | USD 47.70 | -1.25% |
|
Canada |
|
11 |
12.46%
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
12 |
12.36%
|
Dec. 31, 2023 | USD 167.01 | -0.85% |
|
Canada |
|
13 |
12.04%
|
Dec. 31, 2023 | USD 17.67 | 0.98% |
|
Canada |
|
14 |
11.16%
|
Dec. 31, 2023 | USD 125.74 | -0.23% |
|
Canada |
|
15 |
9.59%
|
Jan. 31, 2024 | USD 1.82 | -0.24% |
|
Canada |
|
16 |
4.24%
|
March 30, 2024 | USD 1.77 | 4.73% |
|
Canada |
|
17 |
2.81%
|
Sept. 30, 2024 | USD 1.06 | 0.14% |
|
Canada |
|
18 |
1.54%
|
Dec. 31, 2023 | USD 6.09 | -0.88% |
|
Canada |
|
19 |
-105.28%
|
March 31, 2024 | USD 2.55 | 24.33% |
|
Canada |
|
20 |
-1,146.05%
|
Dec. 31, 2023 | USD 0.15 | -5.56% |
|
Canada |
|
21 |
-3,923.56%
|
Dec. 31, 2023 | USD 5.03 | 6.19% |
|
Canada |
The Eyewear company in Canada with the highest EBITDA Margin is Cipher Pharmaceuticals Inc. (Toronto Stock Exchange: CPH.TO) at 53.21%.
The Eyewear company in Canada with the lowest EBITDA Margin is POET Technologies Inc. (TSXV: PTK.V) at -3,923.56%.
The top 10 Eyewear companies in Canada by EBITDA Margin are Cipher Pharmaceuticals Inc., Lululemon Athletica Inc., Bausch Health Companies Inc., Gildan Activewear Inc., HLS Therapeutics Inc., CCL Industries Inc., Canada Goose Holdings Inc., Medexus Pharmaceuticals Inc., Jamieson Wellness Inc. and Aritzia Inc..
The bottom 10 Eyewear companies in Canada by EBITDA Margin are POET Technologies Inc., Ondine Biomedical Inc., Canopy Growth Corporation, Kits Eyecare Ltd., Unisync Corp., Birks Group Inc., Reitmans (Canada) Limited, Loblaw Companies Limited, Bausch + Lomb Corporation and Boyd Group Services Inc..